Literature DB >> 19241106

Abdominal perineal resection improves survival for nonmetastatic adenocarcinoma of the anal canal.

Nicole Kounalakis1, Avo Artinyan, David Smith, Pablo Mojica-Manoso, Benjamin Paz, Lily L Lai.   

Abstract

BACKGROUND: There remains a lack of consensus regarding the optimal treatment for patients with curable adenocarcinoma of the anal canal (AAC). We sought to determine the role of definitive surgical resection and radiation in a large cohort of patients with AAC.
MATERIALS AND METHODS: We queried the Surveillance, Epidemiology, and End Results (SEER) registry to identify all patients with nonmetastatic AAC from 1988 to 2004 and analyzed clinical factors, treatment modalities, and overall survival in this cohort. Kaplan-Meier survival curves were constructed to compare 5-year overall survival based on treatment groups: abdominal perineal resection (APR) only, APR and external beam radiation (APR and EBR), and EBR only. We performed a Cox regression analysis to determine factors predictive of outcome.
RESULTS: A total of 165 patients were identified with nonmetastatic AAC. Of these, 30 patients were treated with an APR only, 42 patients with an APR and EBR, and 93 patients with EBR only. The 5-year survival for APR only, APR and EBR, and EBR only was 58%, 50%, and 30%, respectively. The difference in survival was statistically significant (APR vs. EBR, P = .02; APR and EBR vs. EBR, P = 0.04). Multivariate analysis completed on 86 patients in this cohort confirmed that factors accounting for the survival differences included age (P = 0.004), nodal stage (P = 0.001), and treatment groups (P = 0.03). The hazard ratio between EBR only compared with APR only was 2.78.
CONCLUSIONS: Definitive surgical treatment in the form of an APR with or without EBR is associated with improved survival in patients with AAC.

Entities:  

Mesh:

Year:  2009        PMID: 19241106     DOI: 10.1245/s10434-009-0392-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  10 in total

1.  Neoplasms of anal canal and perianal skin.

Authors:  Daniel Leonard; David Beddy; Eric J Dozois
Journal:  Clin Colon Rectal Surg       Date:  2011-03

2.  Unusual presentation of mucinous adenocarcinoma in a post fistulectomy case.

Authors:  P J Borpujari; S Bhargava
Journal:  Med J Armed Forces India       Date:  2013-08-20

3.  Surgery and chemotherapy are associated with improved overall survival in anal adenocarcinoma: results of a national cohort study.

Authors:  Nicholas P McKenna; John R Bergquist; Elizabeth B Habermann; Heidi K Chua; Scott R Kelley; Kellie L Mathis
Journal:  Int J Colorectal Dis       Date:  2019-01-11       Impact factor: 2.571

4.  Changing patterns of anal canal carcinoma in the United States.

Authors:  Rebecca A Nelson; Alexandra M Levine; Leslie Bernstein; David D Smith; Lily L Lai
Journal:  J Clin Oncol       Date:  2013-03-18       Impact factor: 44.544

5.  Premalignant lesions of the anal canal and squamous cell carcinoma of the anal canal.

Authors:  Juan Lucas Poggio
Journal:  Clin Colon Rectal Surg       Date:  2011-09

6.  Local excision and chemoradiation for clinical node-negative anal adenocarcinoma.

Authors:  Praveen D Chatani; Dana A Dominguez; John G Aversa; Jeremy L Davis; Jonathan M Hernandez; Lily L Lai; Andrew M Blakely
Journal:  Surg Oncol       Date:  2021-03-31       Impact factor: 2.388

7.  Anal adenocarcinoma: Treatment outcomes and trends in a rare disease entity.

Authors:  Rodney E Wegner; Richard J White; Shaakir Hasan; Moses Raj; Dulabh Monga; Gene Finley; Alexander V Kirichenko; James McCormick
Journal:  Cancer Med       Date:  2019-06-07       Impact factor: 4.452

8.  Clinicopathologic Features and Outcome of Adenocarcinoma of the Anal Canal: A Population-Based Study.

Authors:  Shekhar Gogna; Roberto Bergamaschi; Agon Kajmolli; Mahir Gachabayov; Aram Rojas; David Samson; Rifat Latifi; Xiang Da Dong
Journal:  Int J Surg Oncol       Date:  2020-05-13

Review 9.  Management and Outcomes in Anal Canal Adenocarcinomas-A Systematic Review.

Authors:  Vasilis Taliadoros; Henna Rafique; Shahnawaz Rasheed; Paris Tekkis; Christos Kontovounisios
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575

10.  Metachronous tubulovillous and tubular adenomas of the anal canal.

Authors:  Hiroaki Nozawa; Soichiro Ishihara; Teppei Morikawa; Junichiro Tanaka; Koji Yasuda; Kensuke Ohtani; Takeshi Nishikawa; Toshiaki Tanaka; Tomomichi Kiyomatsu; Kazushige Kawai; Keisuke Hata; Shinsuke Kazama; Hironori Yamaguchi; Eiji Sunami; Joji Kitayama; Masashi Fukayama; Toshiaki Watanabe
Journal:  Diagn Pathol       Date:  2015-08-07       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.